Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Neuropathix Inc market cap is $28,143.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neuropathix Inc 52 week high is $0.0154 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neuropathix Inc 52 week low is $0.0002 as of November 22, 2026.
Neuropathix Inc stock price today is $0.0003.
Neuropathix Inc stock price yesterday was $0.0003.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Neuropathix Inc 50-day moving average is $0.0003.